Explore

Discover daily Discover daily
Pfizer’s COVID-19 Vaccine Required a Complex Network of Global Suppliers

Pfizer’s COVID-19 Vaccine Required a Complex Network of Global Suppliers

The production of the Pfizer-BioNTech COVID-19 vaccine was an unprecedented undertaking, characterized by its speed, scale, and global complexity. ...
Rapid Read Rapid Read
University of Basel Researchers Develop 'Bonsai' Tool for Visualizing Complex Biological Data

University of Basel Researchers Develop 'Bonsai' Tool for Visualizing Complex Biological Data

Researchers at the University of Basel, Switzerland, have developed a new software tool named 'Bonsai' designed to visualize and explore high-dimensional biological data, particularly single-cell RNA sequencing (scRNA-seq) data. Published in Nature Biotechnology, Bonsai reconstructs tree representations of data, placing individual cells at the leaves of branches, where distances along these branches accurately reflect the relationships between cells in high-dimensional space. This approach aims to overcome the limitations of traditional two-dimensional visualization methods, which often distort data and obscure true relationships. The tool has been tested on both simulated and real scRNA-seq datasets, demonstrating superior accuracy in reconstructing developmental pathways and preserving cell-to-cell relationships compared to existing methods like PCA and UMAP. For instance, in analyzing human blood cells, Bonsai not only recovered known relationships but also identified a previously undescribed subtype of...
Asheville Citizen-Times Asheville Citizen-Times
Word from the Smokies: Blow flies could hold the key to preventing disease outbreaks

Word from the Smokies: Blow flies could hold the key to preventing disease outbreaks

For Makhali Voss, going to the lab is synonymous with checking into a hotel.
Rapid Read Rapid Read
Oxford's Malaria Vaccine Trial Shows Favorable Safety and Antibody Responses, Validating ExpreS2 Platform

Oxford's Malaria Vaccine Trial Shows Favorable Safety and Antibody Responses, Validating ExpreS2 Platform

Oxford's Phase Ia trial BIO-002, which investigates the malaria antigen RH5.1, has reported positive results regarding safety and antibody responses. The trial demonstrated that a standard dose of the vaccine provided immunogenicity comparable to a higher dose, indicating efficient and scalable manufacturing potential. This development is part of ExpreS2ion Biotech's partner-driven infectious disease programs, which utilize their proprietary ExpreS2 protein expression platform. The platform is based on genetically modified Drosophila Schneider-2 cells and is also being used for other infectious disease programs, including Nipah virus and influenza, in addition to the company's lead oncology candidate, ES2B-C001. Recruitment for another Oxford-led malaria trial, VAC-099, has also been completed, further highlighting ongoing efforts in malaria research.
Trendline Trendline
SELLAS Life Sciences Group Shares Gain Attention Amidst Broader Oncology Rally

SELLAS Life Sciences Group Shares Gain Attention Amidst Broader Oncology Rally

SELLAS Life Sciences Group Shares Gain Attention Amidst Broader Oncology Rally
Trendline Trendline
Tufts University Establishes Shared R Facility for Cultivated Meat and Alternative Proteins

Tufts University Establishes Shared R Facility for Cultivated Meat and Alternative Proteins

Tufts University Establishes Shared R Facility for Cultivated Meat and Alternative Proteins
Trendline Trendline
EPA Approves New Citrus Greening Treatment Product Developed by University of Florida and Texas A Scientists

EPA Approves New Citrus Greening Treatment Product Developed by University of Florida and Texas A Scientists

EPA Approves New Citrus Greening Treatment Product Developed by University of Florida and Texas A Scientists
Rapid Read Rapid Read
Advancements in Oncogenomics Lead to Improved Prostate Cancer Models

Advancements in Oncogenomics Lead to Improved Prostate Cancer Models

Recent advancements in oncogenomics have significantly enhanced the development of patient-derived models for prostate cancer. These models are designed to accurately reflect the complexity of human tumors, from their initial stages to metastasis. Researchers are utilizing a variety of preclinical models, including primary cultures of prostate epithelial cells (PrECs), co-cultures, patient-derived explants (PDEs), patient-derived organoids (PDOs), and patient-derived xenografts (PDXs). The goal is to improve the fidelity of these models to human tumors by integrating diverse cell types from the tumor microenvironment and mimicking biomechanical features. This involves refining culture methods with matrix components that resemble the tumor microenvironment and developing new media formulations that imitate human plasma, as detailed in a recent review. These sophisticated models allow for detailed experimental readouts, including single-cell and spatial analyses, and intravital imaging for dynamic visualizat...
Rapid Read Rapid Read
Israeli Researchers Develop AI System to Discover Laws of Nature from Scientific Texts

Israeli Researchers Develop AI System to Discover Laws of Nature from Scientific Texts

Israeli researchers from the University of Haifa and the Weizmann Institute of Science have developed an AI system called MEDA, designed to extract fundamental mathematical equations from scientific literature. This system aims to enable large language models to formulate laws of nature, similar to how scientists like Newton or Einstein did. MEDA operates as a 'white box' by scanning scientific papers, translating verbal knowledge into mathematical variables and constraints, and then formulating transparent differential equations. Unlike other AI approaches that use known equations to train networks or focus on processing sensor data, MEDA generates the equations themselves from free-form text. In experiments involving 12 dynamic systems, including predator-prey dynamics and epidemic spread, MEDA successfully identified relevant variables and formulated biologically plausible equations. The study was peer-reviewed, and the system's code has been released as open source.
Trendline Trendline
Biorce Seeks UX Researcher to Advance AI-Powered Clinical Trials in Austin, Texas

Biorce Seeks UX Researcher to Advance AI-Powered Clinical Trials in Austin, Texas

Biorce Seeks UX Researcher to Advance AI-Powered Clinical Trials in Austin, Texas
Trendline Trendline
Multica AI Workspace Integrates 23 Coding Agents for Enhanced Team Collaboration

Multica AI Workspace Integrates 23 Coding Agents for Enhanced Team Collaboration

Multica AI Workspace Integrates 23 Coding Agents for Enhanced Team Collaboration
Rapid Read Rapid Read
Scientist Edward Knipling Pioneered Screwworm Eradication Through Sterile Insect Technique

Scientist Edward Knipling Pioneered Screwworm Eradication Through Sterile Insect Technique

In the 1950s, scientist Edward Knipling initiated a highly successful campaign to combat the New World screwworm, a parasitic insect that inflicted severe damage on livestock and wildlife across the Americas. Knipling's innovative approach, known as the sterile insect technique, involved breeding and releasing millions of sterile male screwworm flies. The objective was to prevent the insects from reproducing, thereby reducing their population. This method proved to be a transformative development in pest control, as detailed in archive recordings from the Special Collections of the United States Department of Agriculture's National Agricultural Library. The BBC World Service podcast 'Witness History' highlighted this significant historical effort, showcasing how Knipling's bold idea led to one of the most effective eradication campaigns in history.